IDEXX LaboratoriesIDXX.OValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, IDEXX Laboratories (IDXX.O) trades at a P/E of 38.70x, P/B of 27.40x, P/S of 9.70x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 5th percentile over the trailing 10Y window (vs. 15th percentile over 3Y); P/B sits at the 16th percentile over the trailing 10Y window (vs. 42nd percentile over 3Y); P/S sits at the 40th percentile over the trailing 10Y window (vs. 27th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 74th percentile within its industry and the 78th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.76%, ranking at the 56th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 11.5 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here lean heavily on buybacks rather than cash dividends. IDEXX Laboratories operates in the Manufacturing sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NASDAQ: IDXX · IDXX
Want the full picture on whether IDEXX Laboratories (IDXX.O) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 38.70 | ||||||
| P/B (MRQ) | 27.40 | ||||||
| P/S (TTM) | 9.70 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 2.76% |